Showing 351-360 of 8894 results for "".
Rising Skin Cancer Rates are a Global Reality
https://practicaldermatology.com/topics/general-topics/PD1009_04-php/20367/One group of researchers questions the skin cancer epidemic, but the overwhelming evidence suggests that rates are rising.6 Tools That Can Benefit Every Dermatology Provider
https://practicaldermatology.com/topics/practice-management/6-tools-that-can-benefit-every-dermatology-provider/23283/Whether you’ve never heard of it or simply forgot about it, each of these tools can improve patient care in the clinic.Clinical Focus: Acne: Back in the Spotlight: Effective Options for Truncal Acne
https://practicaldermatology.com/topics/general-topics/back-in-the-spotlight-effective-options-for-truncal-acne/22031/Data suggest that patients may be unlikely to report truncal acne. Clinicians must assess chest and back involvement and be prepared to offer effective treatments.Strategies to Integrate Skin Care Dispensing
https://practicaldermatology.com/topics/general-topics/strategies-to-integrate-skin-care-dispensing/21569/Dispensing is a way to improve patient care, enhance outcomes, and increase practice revenue.AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.Racism in Medicine and the Problem of Health Care Disparities
https://practicaldermatology.com/topics/skin-of-color/racism-in-medicine-and-the-problem-of-health-care-disparities/23761/Dermatologists can work to improve health outcomes for all patients.Choosing or Evaluating Investment Advisors
https://practicaldermatology.com/topics/practice-management/choosing-or-evaluating-investment-advisors/20566/Tips to help you make the best choice.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Diversity in the Dermatology Workforce: What Can We Do?
https://practicaldermatology.com/topics/practice-management/diversity-in-the-dermatology-workforce-what-can-we-do/23057/Medicine in general lacks workforce diversity. Dermatology fares worse than other specialties. Here’s a closer look at the problem.Prescribing Pitfalls, Part I: Navigate the Changing Landscape of Brand Name Drug Prescribing
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-i-navigate-the-changing-landscape-of-brand-name-drug-prescribing/21440/Prescribers increasingly need to understand drug pricing, pharmacy policies, insurance coverage, and coupon offers to ensure patients get the medications they need.